Farallon Capital Management, L.L.C. / AZNN
Farallon Capital Management, L.L.C.’s Astrazeneca PLC Position
Does Farallon Capital Management, L.L.C. own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 2.41M shares worth $188M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$188M
Q2 2024
Shares
2.41M
% of Portfolio
+0.88%
Quarters Held
16
position exited
Position History AZNN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 2.41M | $188M | +0.88% |
| Q1 2024 | 1.46M | $99M | +0.45% |
| Q4 2023 | 3.82M | $258M | +1.13% |
| Q3 2023 | 6.06M | $410M | +1.76% |
| Q2 2023 | 6.06M | $434M | +2.42% |
| Q1 2023 | 5.87M | $407M | +2.01% |
| Q4 2022 | 5.88M | $398M | +2.61% |
| Q3 2022 | 5.58M | $306M | +1.68% |
| Q2 2022 | 4.63M | $306M | +1.73% |
| Q1 2022 | 3.58M | $237M | +1.04% |
| Q4 2021 | 1.91M | $111M | +0.58% |
| Q3 2021 | 334.0K | $20M | +0.10% |
| Q3 2019 | 2.38M | $106M | +0.88% |
| Q2 2019 | 4.10M | $169M | +1.40% |
| Q1 2019 | 3.88M | $157M | +1.26% |
| Q4 2018 | 3.88M | $148M | +1.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of AZNN.